Journal Home
Search for

Volume 41, Issue 1, Pages 33-38 (February 2007)


View previous. 4 of 9 View next.

S-(+)-fenfluramine-induced nociceptive behavior in mice: Involvement of interactions between spinal serotonin and substance P systems

Koichi Tan-NoaCorresponding Author Informationemail address, Katsuaki Takahashia, Masakazu Shimodaa, Mai Sugawaraa, Osamu Nakagawasaia, Fukie Niijimaa, Takumi Satob, Susumu Satohb, Takeshi Tadanoa

Received 12 August 2006; accepted 11 October 2006. published online 01 December 2006.

Abstract 

Intrathecal (i.t.) administration into mice of S-(+)-fenfluramine (0.01–0.1nmol), a serotonin (5-hydroxytryptamine, 5-HT) releaser, produced a behavioral response consisting of scratching, biting and licking. Here, we report the behavioral characteristics and the involvement of interactions between 5-HT and substance P (SP) systems in the S-(+)-fenfluramine-induced behavioral response. The S-(+)-fenfluramine-induced behavioral response peaked at 5–15min and almost disappeared at 20min after injection. The behavior induced by S-(+)-fenfluramine (0.1nmol) was dose-dependently inhibited by an intraperitoneal injection of morphine (0.02–0.5mg/kg), suggesting that the behavioral response is related to nociception. The S-(+)-fenfluramine-induced nociceptive behavior was significantly inhibited by pretreatment with 5-HT antiserum and co-administration of ketanserin, a selective 5-HT2 receptor antagonist. However, WAY-100635, a selective 5-HT1A receptor antagonist, and ramosetron, a selective 5-HT3 receptor antagonist, were not active. On the other hand, SP antiserum and RP67580, a selective neurokinin-1 (NK1) receptor antagonist, significantly inhibited S-(+)-fenfluramine-induced nociceptive behavior. These results suggest that i.t.-administered S-(+)-fenfluramine releases SP through the activation of 5-HT2 receptors subsequent to 5-HT release, and, as a result, produces nociceptive behavior.

a Department of Pharmacology, Tohoku Pharmaceutical University, 4-4-1 Komatsushima, Aoba-ku, Sendai 981-8558, Japan

b Department of Pharmacology and Pharmacotherapy, Nihon Pharmaceutical University, Kitaadachi-gun, Saitama 362-0806, Japan

Corresponding Author InformationCorresponding author. Tel.: +81 22 727 0123; fax: +81 22 275 2013.

PII: S0143-4179(06)00143-0

doi:10.1016/j.npep.2006.10.003


View previous. 4 of 9 View next.